- Home
- PBYI vs OGI Comparison
PBYI vs OGI Comparison
Compare PBYI & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- OGI
- Stock Information
- Founded
- PBYI 2010
- OGI 2013
- Country
- PBYI United States
- OGI Canada
- Employees
- PBYI N/A
- OGI N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- OGI Biotechnology: Pharmaceutical Preparations
- Sector
- PBYI Health Care
- OGI Health Care
- Exchange
- PBYI Nasdaq
- OGI Nasdaq
- Market Cap
- PBYI 171.7M
- OGI 231.9M
- IPO Year
- PBYI N/A
- OGI N/A
- Fundamental
- Price
- PBYI $4.64
- OGI $1.71
- Analyst Decision
- PBYI Strong Buy
- OGI
- Analyst Count
- PBYI 1
- OGI 0
- Target Price
- PBYI $7.00
- OGI N/A
- AVG Volume (30 Days)
- PBYI 648.1K
- OGI 711.7K
- Earning Date
- PBYI 11-06-2025
- OGI 08-13-2025
- Dividend Yield
- PBYI N/A
- OGI N/A
- EPS Growth
- PBYI 434.29
- OGI N/A
- EPS
- PBYI 0.97
- OGI 0.05
- Revenue
- PBYI $238,062,000.00
- OGI $164,107,753.00
- Revenue This Year
- PBYI N/A
- OGI $58.15
- Revenue Next Year
- PBYI N/A
- OGI $14.60
- P/E Ratio
- PBYI $4.76
- OGI $33.85
- Revenue Growth
- PBYI 8.63
- OGI 50.01
- 52 Week Low
- PBYI $2.32
- OGI $0.85
- 52 Week High
- PBYI $6.07
- OGI $2.00
- Technical
- Relative Strength Index (RSI)
- PBYI 49.99
- OGI 63.11
- Support Level
- PBYI $4.49
- OGI $1.56
- Resistance Level
- PBYI $5.22
- OGI $1.70
- Average True Range (ATR)
- PBYI 0.26
- OGI 0.07
- MACD
- PBYI -0.12
- OGI -0.00
- Stochastic Oscillator
- PBYI 22.33
- OGI 68.18
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.